Register for free
Recent Quotes
My Watchlist
Indicators
Business Insurance Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about ALPMF

Recent news which mentions ALPMF

Syfovre's Competitive Edge Highlights Bright Future For Apellis Pharmaceuticals, Analyst Initiates With Bullish Pitch
Tickers ALPMF ALPMY APLS NEWS
Tags Biotech ALPMF Benzinga
From Benzinga
Small-Cap Cancer-Focused Nuvation Bio Pulls Plug On Early-Stage Program After Considering Phase 1 Solid Tumor Data
Tickers ALPMF ALPMY AZN MRK
Tags Benzinga Stories That Matter ALPMF
From Benzinga
Bayer Highlights Detailed Data From Twin Late-Stage Trials On Experimental Menopause Candidate, Seeks Regulatory Approval
Tickers ALPMF BAYRY BAYZF DARE
Tags General Stories That Matter BAYZF
From Benzinga
Merck's Best Selling Cancer Drug Meets One Goal In Late-Stage Bladder Cancer Study
Tickers ALPMF ALPMY MRK SGEN
Tags Large Cap Briefs News
From Benzinga
Why Is Seagen Stock Trading Higher Today?
Tickers ALPMF ALPMY MRK SGEN
Tags why it's moving General MRK
From Benzinga
What's Going On With Neurology Focused Taysha Gene Therapies Stock Today?
Tickers ALPMF ALPMY TSHA
Tags Market News why it's moving Contracts
From Benzinga
Why Shares of Adaptive Biotechnologies Jumped This Week
Tickers ADPT ALPMF
Tags ADPT ALPMF Recent Press Releases
From Motley Fool
Astellas Pharma Licenses Promising Gene Therapy KT430 from Kate Therapeutics Amidst Clinical Hurdles
Tickers ALPMF ALPMY
Tags News Briefs ALPMF
From Benzinga
Eye Care Sector Sees Several Large Acquisitions – Could This Ticker Be On Route For The Next Big Acquisition?
Tickers ALPMF ISEE OKYO VTRS
Tags ISEE Health Care Penny Stocks
From Benzinga
Google Launches Tools To Detect Fake Images, Apple May Encounter Delays In iPhone 15 Production, Shake Shack Sees Activist Investor Proxy Fight: Today's Top Stories
Tickers AAPL ALPMF ALPMY BTI
Tags OKE NCMGY Markets
From Benzinga
Astellas' Menopause Drug Sores FDA Approval, After Regulatory Setback
Tickers ALPMF ALPMY
Tags ALPMY Biotech ALPMF
From Benzinga
Pfizer, Astellas' Xtandi Combo Therapy Cuts Risk Of Metastasis, Death In Prostate Cancer By 58%
Tickers ALPMF ALPMY PFE
Tags Benzinga Health Care ALPMF
From Benzinga
Astellas Pharma Acquires Iveric Bio For $5.9B To Focus On 'Blindness & Regeneration'
Tickers ALPMF ALPMY ISEE
Tags M&A Market News General
From Benzinga
FDA Approves Merck's Keytruda Combined With Seagen/Astellas's Padcev For Advanced Urothelial Cancer
Tickers ALPMF ALPMY MRK SGEN
Tags Biotech ALPMY ALPMF
From Benzinga
AbbVie Walks Away From CytomX Partnership, But Garnering Attention Of Big Pharma Partners
Tickers ABBV ALPMF BMY CTMX
Tags BMY why it's moving Contracts
From Benzinga
Japanese Government Urges China To Release Astellas Pharma's Employee
Tickers ALPMF ALPMY
Tags ALPMY Health Care News
From Benzinga
Pfizer, Astellas Tout Positive Xtandi Data To Potentially Expand Label For The Prostate Cancer Drug
Tickers ALPMF ALPMY PFE
Tags General Market News PFE
From Benzinga
Analyst Says Selecta Biosciences' Gout Candidate Can Potentially Raise The Bar On Several Fronts
Tickers ALPMF ALPMY HZNP SELB
Tags General Biotech ALPMF
From Benzinga
Sandoz Acquires Antifungal Agent From Astellas, Reinforcing Hospital Offering
Tickers ALPMF ALPMY GSK NVS
Tags Briefs Benzinga ALPMF
From Benzinga
Astellas Pharma Invests $50M To Support Taysha's Gene Therapy Programs
Tickers ALPMF ALPMY TSHA
Tags Briefs ALPMF Movers
From Benzinga
Astellas' Menopause Drug Under FDA Review
Tickers ALPMF ALPMY
Tags General FDA Market News
From Benzinga
Seagen's Bladder Cancer Trial Data Meets Expectation, Analysts Say
Tickers ALPMF SGEN
Tags Health Care Trading Ideas Analyst Ratings
From Benzinga
Daily Biotech Pulse: EU Approval For AbbVie's Ulcerative Colitis Treatment, Angion Biomedica Evaluates Alternatives, Clinical Hold For Immuron's Bacterial Infection Candidate
Tickers ABBV ALPMF ANGN BIIB
Tags Offerings News OWLT
From Benzinga
Seagen Shares Jump On Positive Data From Urothelial Cancer Trial
Tickers ALPMF ALPMY MRK SGEN
Tags Benzinga Movers Biotech
From Benzinga
The Daily Biotech Pulse: Kezar Life Surges On Positive Kidney Disease Trial Data, FDA Rejects Spero Therapeutics' Tebipenem, Graybug Reviews Strategic Alternatives
Tickers ALPMF CNTG ELYM EPIX
Tags Benzinga ELYM ALPMF
From Benzinga
Sutro Biopharma Stock Surges On Cancer Treatment Pact
Tickers ALPMF ALPMY STRO
Tags Market News Contracts why it's moving
From Benzinga
The Daily Biotech Pulse: CHMP Backs AstraZeneca's Breast Cancer Therapies, Ipsen Buys Epizyme, FDA Holds For Nuvation Bio, Astellas Studies
Tickers ALPMF ALPMY AXSM AZN
Tags NUVB BNTX M&A
From Benzinga
Astellas's Pompe Disease Gene Therapy Trial Put On FDA Clinical Hold
Tickers ALPMF ALPMY
Tags FDA General Market News
From Benzinga
Twist Bioscience, Astellas Join Forces To Develop Cancer Targeting Antibodies
Tickers ALPMF ALPMY TWST
Tags TWST Small Cap General
From Benzinga
Astellas - Seagen's Padcev Approved In Europe For Most Common Form Of Bladder Cancer
Tickers ALPMF ALPMY SGEN
Tags Market News SGEN European Medicines Agency
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.

Never miss important news. Subscribe to our newsletter.
Register for free

Information

Copyright 2024. BUSINESS INSURANCE HOLDINGS